HLA-A2 Antikörper
Kurzübersicht für HLA-A2 Antikörper (ABIN2474042)
Target
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
- 
    - 
                                            Produktmerkmale
- Purified IgG
- 
                                            Endotoxin-Niveau
- Low endotoxin
- 
                                            Isotyp
- IgG2b
 
- 
                                            
- 
    
- 
    - 
                                            Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- 
                                            Beschränkungen
- Nur für Forschungszwecke einsetzbar
 
- 
                                            
- 
    - 
                                            Format
- Liquid
- 
                                            Konzentration
- 1.0 mg/mL
 
- 
                                            
- 
    - 
                                            : "Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells."    in: Stem cells (Dayton, Ohio), Vol. 24, Issue 2, pp. 221-9, (2006)         (PubMed).        
 : "Induction of cytotoxic T-cell responses against immunoglobulin V region-derived peptides modified at human leukocyte antigen-A2 binding residues." in: Blood, Vol. 98, Issue 10, pp. 2999-3005, (2001) (PubMed).
 
 
- 
                                            : "Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells."    in: Stem cells (Dayton, Ohio), Vol. 24, Issue 2, pp. 221-9, (2006)         (PubMed).        
- 
    - HLA-A2
- 
                                            Andere Bezeichnung
- HLA A2
- 
                                            Substanzklasse
- Influenza Protein
- 
                                            Gen-ID
- 3105
- 
                                            UniProt
- P01892
 Target
- 
                    
 
                                     
                                     
                                    